FS Development Holdings LLC 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-12 4:46 pm Unchanged | 2022-08-09 | 13D | Gemini Therapeutics, Inc. GMTX | FS Development Holdings LLC | 487,025 11.260% | 0 (Unchanged) | Filing |
| 2021-02-12 4:39 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | FS Development Holdings LLC | 487,025 10.750% | 487,025 (New Position) | Filing |